Akari Therapeutics (AKTX)
undefined
undefined%
At close: undefined
0.97
-2.70%
After-hours Dec 13, 2024, 03:59 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
Revenue - - - - - - - - - - - - - -
Cost of Revenue 4.00K 3.71K 4.13K 8.91K 19.20K 35.85K 42.40K 39.77K 10.16K - - - - -
Gross Profit -4.00K -3.71K -4.13K -8.91K -19.20K -35.85K -42.40K -39.77K -10.16K - - - - -
Operating Income -16.81M -23.09M -17.21M -17.98M -24.87M -19.99M -34.96M -27.25M -30.58M -10.18M -3.61M -3.67M -2.25M -792.00K
Interest Income 82.00K 45.94K 10.60K 13.00K 5.00K 222.26K 175.39K 143.19K 20.70K - - 440.00K - 122.00K
Pretax Income -10.01M -17.75M -17.42M -20.45M -24.75M -23.50M -32.57M -18.14M -45.32M -9.65M -3.62M -1.44M -2.12M -675.00K
Net Income -10.01M -6.97M -17.61M -17.60M -21.76M -19.95M -27.92M -18.14M -45.32M -9.65M -3.62M -1.44M -2.12M -675.00K
Selling & General & Admin 11.36M 13.53M 8.08M 7.91M 8.22M 10.90M 11.67M 9.94M 5.50M 3.76M 2.33M 734.00K 1.41M 545.00K
Research & Development 12.13M 9.56M 9.13M 12.19M 16.65M 15.59M 23.29M 17.31M 5.80M 6.42M 1.28M 1.02M 841.00K 247.00K
Other Expenses -6.68M 802.79K -27.48K -22.01K 19.00K -2.68M -13.39K -43.97K -44.22K - - - - -
Operating Expenses 16.81M 23.89M 17.21M 20.10M 24.89M 23.80M 34.96M 27.25M 11.30M 10.18M 3.61M 1.75M 2.25M 792.00K
Interest Expense - - - - - - - 9.15M 3.05M - 202.00K 1.04M - 5.00K
Selling & Marketing Expenses - - - - - - - - - - - - - -
Cost & Expenses 16.81M 23.09M 17.21M 20.10M 24.89M 23.80M 34.96M 27.25M 11.30M 10.18M 3.61M 1.75M 2.25M 792.00K
Income Tax - -10.78M 182.62K -2.86M -2.99M -3.55M -4.65M -43.97K 3.01M - 202.00K 1.92M 9.00K -
Shares Outstanding (Basic) 4.89M 3.12M 2.15M 1.58M 915.50K 15.81M 12.47M 11.78M 8.52M 855.16K 210.75K 124.59K 133.70K 133.70K
Shares Outstanding (Diluted) 4.89M 3.12M 2.15M 1.58M 915.50K 15.81M 12.47M 11.78M 8.52M 855.16K 210.75K 124.59K 133.70K 133.70K
EPS (Basic) -2.04 -2.23 -8.2 -11.14 -23.77 -1.26 -2.24 -1.54 -5.32 -11.28 -17.18 -11.52 -15.85 -5.05
EPS (Diluted) -2.04 -2.23 -8.2 -11.14 -23.77 -1.26 -2.24 -1.54 -5.32 -11.28 -17.18 -11.52 -15.85 -5.05
EBITDA -16.80M -23.08M -17.21M -20.44M -24.73M -16.43M -35.36M -27.25M -19.28M -10.19M -3.42M -3.36M -2.12M -675.88K
Depreciation & Amortization 4.00K 3.71K 4.13K 8.91K 19.20K 35.85K 42.40K 39.77K 10.16K 8.00K 2.00K 2.00K -137.00K -